Target Site Pharmacokinetics of Meropenem: Measurement in Human Explanted Lung Tissue by Bronchoalveolar Lavage, Microdialysis, and Homogenized Lung Tissue-Reference-Cited by-同舟云学术

Target Site Pharmacokinetics of Meropenem: Measurement in Human Explanted Lung Tissue by Bronchoalveolar Lavage, Microdialysis, and Homogenized Lung Tissue

Published:2021-11-17 Issue:12 Volume:65 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Paal Michael¹,Scharf Christina²,Denninger Ann Katrin²,Ilia Luis³,Kloft Charlotte³,Kneidinger Nikolaus⁴,Liebchen Uwe²³,Michel Sebastian⁵,Schneider Christian⁶,Schröpf Sebastian⁷,Schuster Carina¹,Vogeser Michael¹,Weinelt Ferdinand³⁸,Zander Johannes¹⁹,Zoller Michael²,Schroeder Ines²^ORCID

Affiliation:

1. Institute of Laboratory Medicine, University Hospital, LMU Munich, Munich, Germany

2. Department of Anaesthesiology, University Hospital, LMU Munich, Munich, Germany

3. Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Berlin, Germany

4. Department of Internal Medicine V, University Hospital, LMU Munich, Comprehensive Pneumology Center, Munich, Germany

5. Clinic of Cardiac Surgery, University Hospital, LMU Munich, Munich, Germany

6. Department of Thoracic Surgery, University Hospital, LMU Munich, Munich, Germany

7. Dr von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany

8. Graduate Research Training Program PharMetrX, Berlin, Germany

9. Laboratory Dr. Brunner, Constance, Germany

Abstract

Pneumonia is one of the most common infections in intensive care patients, and it is often treated with beta-lactam antibiotics. Even if therapeutic drug monitoring in blood is available, it is unclear whether sufficient concentrations are reached at the target site: the lung.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01564-21

Reference35 articles.

1. Rates and risk factors associated with hospitalization for pneumonia with ICU admission among adults

2. Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

3. The ONTAI study – a survey on antimicrobial dosing and the practice of therapeutic drug monitoring in German intensive care units

4. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#

5. Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation—SFAR)

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacteriophages as potential antibiotic potentiators in cystic fibrosis: A new model to study the combination of antibiotics with a bacteriophage cocktail targeting dual species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa;International Journal of Antimicrobial Agents;2024-09

2. Effects of lung inflammation and injury on pulmonary tissue penetration of meropenem and vancomycin in a model of unilateral lung injury;International Journal of Antimicrobial Agents;2024-07

3. Can linezolid be validly measured in endotracheal aspiration in critically ill patients? A proof-of-concept trial;Intensive Care Medicine Experimental;2024-05-08

4. Understanding the nebulisation of antibiotics: the key role of lung microdialysis studies;Critical Care;2024-02-19

5. Antimicrobial Drug Penetration is Enhanced by Lung Tissue Inflammation and Injury;American Journal of Respiratory and Critical Care Medicine;2023-12-15